129 related articles for article (PubMed ID: 15761230)
1. Acromegaly and serum insulin-like growth factor I.
Thorner MO
Horm Res; 2004; 62 Suppl 1():34-6. PubMed ID: 15761230
[TBL] [Abstract][Full Text] [Related]
2. Serum IGF-I measured by four different immunoassays in patients with adult GH deficiency or acromegaly and in a control population.
Granada ML; Ulied A; Casanueva FF; Pico A; Lucas T; Torres E; Sanmartí A
Clin Endocrinol (Oxf); 2008 Jun; 68(6):942-50. PubMed ID: 17980002
[TBL] [Abstract][Full Text] [Related]
3. IGF-I and mortality in patients with acromegaly.
Strasburger CJ
J Endocrinol Invest; 2005; 28(11 Suppl International):78-80. PubMed ID: 16625852
[TBL] [Abstract][Full Text] [Related]
4. Clinical utility of measurements of insulin-like growth factor 1.
Clemmons DR
Nat Clin Pract Endocrinol Metab; 2006 Aug; 2(8):436-46. PubMed ID: 16932333
[TBL] [Abstract][Full Text] [Related]
5. [The place of insulin-like growth factor I in the diagnosis of acromegaly].
Dohán O; Góth M; Szabolcs I; Kovács L; Kovács Z; Szilágyi G
Orv Hetil; 1993 Oct; 134(42):2301-3. PubMed ID: 8233444
[TBL] [Abstract][Full Text] [Related]
6. Serum insulin-like growth factor-I measurement in the follow-up of treated acromegaly: comparison of four immunoassays.
Massart C; Poirier JY
Clin Chim Acta; 2006 Nov; 373(1-2):176-9. PubMed ID: 16815351
[TBL] [Abstract][Full Text] [Related]
7. Dynamic tests and basal values for defining active acromegaly.
Tzanela M
Neuroendocrinology; 2006; 83(3-4):200-4. PubMed ID: 17047383
[TBL] [Abstract][Full Text] [Related]
8. Clinical laboratory indices in the treatment of acromegaly.
Clemmons DR
Clin Chim Acta; 2011 Feb; 412(5-6):403-9. PubMed ID: 21075098
[TBL] [Abstract][Full Text] [Related]
9. The effects of long-term growth hormone and insulin-like growth factor-1 exposure on the development of cardiovascular, cerebrovascular and metabolic co-morbidities in treated patients with acromegaly.
Jayasena CN; Comninos AN; Clarke H; Donaldson M; Meeran K; Dhillo WS
Clin Endocrinol (Oxf); 2011 Aug; 75(2):220-5. PubMed ID: 21521288
[TBL] [Abstract][Full Text] [Related]
10. Clinical indicators of biochemical remission in acromegaly: does incomplete disease control always mean therapeutic failure?
Damjanovic SS; Neskovic AN; Petakov MS; Popovic V; Macut D; Vukojevic P; Joksimovic MM
Clin Endocrinol (Oxf); 2005 Apr; 62(4):410-7. PubMed ID: 15807870
[TBL] [Abstract][Full Text] [Related]
11. Pregnancy-induced changes in insulin-like growth factor I (IGF-I), insulin-like growth factor binding protein 3 (IGFBP-3), and acid-labile subunit (ALS) in patients with growth hormone (GH) deficiency and excess.
Wiesli P; Zwimpfer C; Zapf J; Schmid C
Acta Obstet Gynecol Scand; 2006; 85(8):900-5. PubMed ID: 16862465
[TBL] [Abstract][Full Text] [Related]
12. [What is the value of determining immunoreactive GHRH in acromegaly?].
Müller B; de Marco D; Bürgi U; Mullis PE
Schweiz Med Wochenschr; 1999 Aug; 129(33):1152-61. PubMed ID: 10483668
[TBL] [Abstract][Full Text] [Related]
13. Hormonal diagnosis of GH hypersecretory states.
Grottoli S; Gasco V; Ragazzoni F; Ghigo E
J Endocrinol Invest; 2003; 26(10 Suppl):27-35. PubMed ID: 15497657
[TBL] [Abstract][Full Text] [Related]
14. Insulin-like growth factor binding protein-3 levels during early and late follow-up after surgery in acromegalic patients.
Charalampaki P; Hildebrandt G; Schaeffer HJ; Schönau E; Klug N
Exp Clin Endocrinol Diabetes; 1998; 106(2):130-4. PubMed ID: 9628244
[TBL] [Abstract][Full Text] [Related]
15. Pitfalls of insulin-like growth factor I assays.
Bidlingmaier M
Horm Res; 2009 Jan; 71 Suppl 1():30-3. PubMed ID: 19153502
[TBL] [Abstract][Full Text] [Related]
16. Acromegaly: the significance of serum total and free IGF-I and IGF-binding protein-3 in diagnosis.
van der Lely AJ; de Herder WW; Janssen JA; Lamberts SW
J Endocrinol; 1997 Oct; 155 Suppl 1():S9-13; discussion S15-6. PubMed ID: 9389990
[TBL] [Abstract][Full Text] [Related]
17. [Study on the activity of acromegaly: evaluation of IGF-I].
Larrañaga J; Carbó E; Horcajada C; Herrera Pombo JL
Rev Clin Esp; 1991 Feb; 188(3):131-5. PubMed ID: 1780511
[TBL] [Abstract][Full Text] [Related]
18. Long-term monitoring of insulin-like growth factor I in adult growth hormone deficiency: a critical appraisal.
Gibney J; Johannsson G
Horm Res; 2004; 62 Suppl 1():66-72. PubMed ID: 15761235
[TBL] [Abstract][Full Text] [Related]
19. Role of insulin-like growth factor-I in diagnosis and management of acromegaly.
Clemmons DR
Endocr Pract; 2004; 10(4):362-71. PubMed ID: 15760781
[TBL] [Abstract][Full Text] [Related]
20. Treatment of acromegaly with octreotide-LAR: extensive experience in a Brazilian institution.
Jallad RS; Musolino NR; Salgado LR; Bronstein MD
Clin Endocrinol (Oxf); 2005 Aug; 63(2):168-75. PubMed ID: 16060910
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
